Kurt Huber

发表

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

S. Yusuf, M. Ezekowitz, J. Healey, 2011, Circulation.

D‐dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation – observations from the ARISTOTLE trial

E. Hylek, A. Siegbahn, L. Wallentin, 2014, Journal of thrombosis and haemostasis : JTH.